Renalys Pharma, Inc. develops innovative therapeutics to improve the management of renal diseases for patients in Japan and Asia.

Renalys

reCAPTCHA

Cloudflare Hosting

Japanese Yen

Ryutaro Shimazaki

Chief Development Officer

Takeshi Takahashi

Chief Financial Officer & Co-Founder

BT Slingsby

Chief Executive Officer & Co-Founder

Keisuke Kobayashi

Chief Operating Officer

City of Tokyo Companies With Less Than $500M in Revenue

Nippon Venture Capital Portfolio Companies

Asia Early Stage Companies With Fewer Than 1000 Employees (Top 10K)

Asia-Pacific (APAC) Companies With Fewer Than 1000 Employees (Top 10K)

Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.

Catalys Pacific

SR One

Series A - Renalys Pharma

Tokyo

Japan

Asia

Renalys Pharma

Renalys Pharma closes ¥6bn series A financing for kidney disease treatments in Asia

Renalys Pharma Closes ¥6.0Bn Series A Financing

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Jul 28, 2024 11:04 PM	9b5a8b09
public peers	general	Jul 28, 2024 9:54 PM	820816bf
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 28, 2024 10:57 PM	3c2853fe
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:50 PM	ea63a5af
crunchbase profile	general	Oct 29, 2024 9:03 AM	98508884
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	79ad4cad
peers	general	Jul 28, 2024 9:54 PM	2464e750
news basic	general	Jul 28, 2024 9:54 PM	771ae762
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

RENA

COM:RENALYS

Renalys